| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Domain | DUF1088 | 2.40e-05 | 2 | 92 | 2 | IPR010508 | |
| Domain | DUF1088 | 2.40e-05 | 2 | 92 | 2 | PF06469 | |
| Domain | TOM1 | 7.18e-05 | 3 | 92 | 2 | IPR014645 | |
| Domain | WD40_repeat_dom | 1.09e-04 | 297 | 92 | 8 | IPR017986 | |
| Domain | DUF4704 | 2.38e-04 | 5 | 92 | 2 | IPR031570 | |
| Domain | DUF4704 | 2.38e-04 | 5 | 92 | 2 | PF15787 | |
| Domain | - | 2.38e-04 | 333 | 92 | 8 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 2.48e-04 | 335 | 92 | 8 | IPR015943 | |
| Domain | PH_BEACH | 3.55e-04 | 6 | 92 | 2 | PF14844 | |
| Domain | GAT_dom | 3.55e-04 | 6 | 92 | 2 | IPR004152 | |
| Domain | - | 3.55e-04 | 6 | 92 | 2 | 1.20.58.160 | |
| Domain | GAT | 3.55e-04 | 6 | 92 | 2 | PS50909 | |
| Domain | GAT | 3.55e-04 | 6 | 92 | 2 | PF03127 | |
| Domain | ENTH_VHS | 3.85e-04 | 29 | 92 | 3 | IPR008942 | |
| Domain | WD40_repeat | 3.93e-04 | 272 | 92 | 7 | IPR001680 | |
| Domain | WD_REPEATS_1 | 4.47e-04 | 278 | 92 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 4.57e-04 | 279 | 92 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 4.57e-04 | 279 | 92 | 7 | PS50294 | |
| Domain | STAT_TF_DNA-bd_sub | 4.96e-04 | 7 | 92 | 2 | IPR012345 | |
| Domain | STAT | 4.96e-04 | 7 | 92 | 2 | IPR001217 | |
| Domain | STAT_int | 4.96e-04 | 7 | 92 | 2 | SM00964 | |
| Domain | STAT_TF_DNA-bd | 4.96e-04 | 7 | 92 | 2 | IPR013801 | |
| Domain | STAT_bind | 4.96e-04 | 7 | 92 | 2 | PF02864 | |
| Domain | STAT_int | 4.96e-04 | 7 | 92 | 2 | PF02865 | |
| Domain | - | 4.96e-04 | 7 | 92 | 2 | 1.10.532.10 | |
| Domain | STAT_alpha | 4.96e-04 | 7 | 92 | 2 | PF01017 | |
| Domain | - | 4.96e-04 | 7 | 92 | 2 | 1.20.1050.20 | |
| Domain | STAT_TF_prot_interaction | 4.96e-04 | 7 | 92 | 2 | IPR013799 | |
| Domain | STAT_TF_coiled-coil | 4.96e-04 | 7 | 92 | 2 | IPR015988 | |
| Domain | - | 4.96e-04 | 7 | 92 | 2 | 2.60.40.630 | |
| Domain | STAT_TF_alpha | 6.59e-04 | 8 | 92 | 2 | IPR013800 | |
| Domain | PH-BEACH_dom | 6.59e-04 | 8 | 92 | 2 | IPR023362 | |
| Domain | - | 6.59e-04 | 8 | 92 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 6.59e-04 | 8 | 92 | 2 | PS51783 | |
| Domain | ConA-like_dom | 7.48e-04 | 219 | 92 | 6 | IPR013320 | |
| Domain | VHS | 8.45e-04 | 9 | 92 | 2 | PS50179 | |
| Domain | BEACH | 8.45e-04 | 9 | 92 | 2 | PS50197 | |
| Domain | Beach | 8.45e-04 | 9 | 92 | 2 | PF02138 | |
| Domain | - | 8.45e-04 | 9 | 92 | 2 | 1.10.1540.10 | |
| Domain | Beach | 8.45e-04 | 9 | 92 | 2 | SM01026 | |
| Domain | BEACH_dom | 8.45e-04 | 9 | 92 | 2 | IPR000409 | |
| Domain | VHS | 8.45e-04 | 9 | 92 | 2 | PF00790 | |
| Domain | VHS | 8.45e-04 | 9 | 92 | 2 | SM00288 | |
| Domain | VHS_dom | 8.45e-04 | 9 | 92 | 2 | IPR002014 | |
| Domain | PH_dom-like | 1.20e-03 | 426 | 92 | 8 | IPR011993 | |
| Domain | ARM-type_fold | 1.43e-03 | 339 | 92 | 7 | IPR016024 | |
| Domain | WD40 | 1.77e-03 | 259 | 92 | 6 | PF00400 | |
| Domain | WD40 | 2.10e-03 | 268 | 92 | 6 | SM00320 | |
| Domain | Quinoprotein_ADH-like_supfam | 2.27e-03 | 53 | 92 | 3 | IPR011047 | |
| Domain | N2O_reductase_N | 2.42e-03 | 15 | 92 | 2 | IPR011045 | |
| Domain | AT_hook | 2.75e-03 | 16 | 92 | 2 | PF02178 | |
| Domain | EF-hand-dom_pair | 2.95e-03 | 287 | 92 | 6 | IPR011992 | |
| Domain | PRAME_family | 3.89e-03 | 19 | 92 | 2 | IPR026271 | |
| Domain | CH | 4.05e-03 | 65 | 92 | 3 | SM00033 | |
| Pathway | REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS | 1.13e-06 | 18 | 64 | 4 | M673 | |
| Pathway | REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION | 1.11e-05 | 31 | 64 | 4 | M661 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE | 2.54e-05 | 38 | 64 | 4 | M27536 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 3.13e-05 | 14 | 64 | 3 | M27858 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 3.91e-05 | 15 | 64 | 3 | MM14536 | |
| Pathway | REACTOME_SIGNALING_BY_FGFR_IN_DISEASE | 1.88e-04 | 63 | 64 | 4 | M635 | |
| Pathway | KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY | 2.01e-04 | 5 | 64 | 2 | M48987 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 3.01e-04 | 6 | 64 | 2 | MM15581 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 3.01e-04 | 6 | 64 | 2 | MM15621 | |
| Pathway | REACTOME_SIGNALING_BY_CSF3_G_CSF | 3.32e-04 | 30 | 64 | 3 | M41825 | |
| Pathway | REACTOME_STAT5_ACTIVATION | 4.20e-04 | 7 | 64 | 2 | M27953 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY | 4.20e-04 | 7 | 64 | 2 | M47430 | |
| Pathway | REACTOME_INTERLEUKIN_7_SIGNALING | 5.73e-04 | 36 | 64 | 3 | M542 | |
| Pathway | PID_GMCSF_PATHWAY | 5.73e-04 | 36 | 64 | 3 | M22 | |
| Pathway | WP_IL2_SIGNALING_PATHWAY | 6.48e-04 | 87 | 64 | 4 | MM15915 | |
| Pathway | REACTOME_INTERLEUKIN_9_SIGNALING | 7.16e-04 | 9 | 64 | 2 | M27861 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 7.16e-04 | 9 | 64 | 2 | MM1419 | |
| Pathway | BIOCARTA_IL22BP_PATHWAY | 7.16e-04 | 9 | 64 | 2 | M8066 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | 8.92e-04 | 10 | 64 | 2 | MM14644 | |
| Pathway | REACTOME_INTERLEUKIN_21_SIGNALING | 8.92e-04 | 10 | 64 | 2 | M27898 | |
| Pathway | REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS | 8.92e-04 | 10 | 64 | 2 | M41731 | |
| Pathway | WP_IL2_SIGNALING | 9.03e-04 | 42 | 64 | 3 | M39536 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 9.68e-04 | 43 | 64 | 3 | M508 | |
| Pathway | REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING | 1.03e-03 | 44 | 64 | 3 | M1012 | |
| Pathway | REACTOME_SIGNALING_BY_LEPTIN | 1.09e-03 | 11 | 64 | 2 | M27195 | |
| Pathway | REACTOME_INTERLEUKIN_15_SIGNALING | 1.09e-03 | 11 | 64 | 2 | MM15578 | |
| Pathway | REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE | 1.09e-03 | 11 | 64 | 2 | M655 | |
| Pathway | WP_IL3_SIGNALING_PATHWAY | 1.09e-03 | 100 | 64 | 4 | MM15879 | |
| Pathway | WP_IL6_SIGNALING_PATHWAY | 1.09e-03 | 100 | 64 | 4 | MM15826 | |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | 1.18e-03 | 102 | 64 | 4 | MM15430 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 1.25e-03 | 47 | 64 | 3 | M39380 | |
| Pathway | WP_IL3_SIGNALING | 1.42e-03 | 49 | 64 | 3 | M39722 | |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 1.50e-03 | 50 | 64 | 3 | MM15308 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 1.61e-03 | 188 | 64 | 5 | MM15828 | |
| Pathway | WP_IL4_SIGNALING | 1.88e-03 | 54 | 64 | 3 | M39720 | |
| Pathway | PID_IL2_1PATHWAY | 1.98e-03 | 55 | 64 | 3 | M122 | |
| Pathway | WP_FOXP3_IN_COVID19 | 2.05e-03 | 15 | 64 | 2 | M42573 | |
| Pubmed | 2.10e-08 | 3 | 97 | 3 | 19581930 | ||
| Pubmed | 8.40e-08 | 4 | 97 | 3 | 19258595 | ||
| Pubmed | Gab2 promotes hematopoietic stem cell maintenance and self-renewal synergistically with STAT5. | 8.40e-08 | 4 | 97 | 3 | 20161778 | |
| Pubmed | 8.40e-08 | 4 | 97 | 3 | 17353274 | ||
| Pubmed | AMFR IQGAP2 RRP1B BMP2K RBBP7 VPS8 TOM1 CHD4 NCLN PRPF8 STAT3 PIK3C2A CCAR2 EXOC1 UBE3C SDHA PPP6R3 | 4.61e-07 | 1440 | 97 | 17 | 30833792 | |
| Pubmed | 1.11e-06 | 28 | 97 | 4 | 25089626 | ||
| Pubmed | 1.42e-06 | 285 | 97 | 8 | 34369648 | ||
| Pubmed | 1.74e-06 | 129 | 97 | 6 | 23022380 | ||
| Pubmed | 4.33e-06 | 151 | 97 | 6 | 17043677 | ||
| Pubmed | 4.54e-06 | 12 | 97 | 3 | 9885572 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | AMFR MIS18BP1 RRP1B BMP2K RBBP7 CHD4 NCLN PRPF8 VIRMA STAT3 MRC2 PTRHD1 MED23 PPP6R3 | 6.27e-06 | 1203 | 97 | 14 | 29180619 |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20535152 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20167868 | ||
| Pubmed | Gads/Grb2-mediated association with LAT is critical for the inhibitory function of Gab2 in T cells. | 7.70e-06 | 2 | 97 | 2 | 12640133 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 16275030 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 17310989 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 11449275 | ||
| Pubmed | The absence of Grb2-associated binder 2 (Gab2) does not disrupt NK cell development and functions. | 7.70e-06 | 2 | 97 | 2 | 15240750 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 9885561 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 35411035 | ||
| Pubmed | Requirement of Gab2 for mast cell development and KitL/c-Kit signaling. | 7.70e-06 | 2 | 97 | 2 | 11861309 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 32437087 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 23796711 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 16369543 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27282405 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 16009726 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22959364 | ||
| Pubmed | Grb2 associated binder 2 couples B-cell receptor to cell survival. | 7.70e-06 | 2 | 97 | 2 | 18950707 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 27125306 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 37937666 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 18577706 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 26773044 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 36007472 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 25487443 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 33637697 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 20089858 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 17374739 | ||
| Pubmed | Gab2 plays distinct roles in bone homeostasis at different time points. | 7.70e-06 | 2 | 97 | 2 | 17323176 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 33827252 | ||
| Pubmed | Docking protein Gab2 positively regulates glycoprotein VI-mediated platelet activation. | 7.70e-06 | 2 | 97 | 2 | 16198316 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 24805943 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 11830491 | ||
| Pubmed | The ubiquitin ligase gp78 promotes sarcoma metastasis by targeting KAI1 for degradation. | 7.70e-06 | 2 | 97 | 2 | 18037895 | |
| Pubmed | Uncovering the pathogenesis of large granular lymphocytic leukemia-novel STAT3 and STAT5b mutations. | 7.70e-06 | 2 | 97 | 2 | 24512550 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 22859374 | ||
| Pubmed | Activating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells. | 7.70e-06 | 2 | 97 | 2 | 25586472 | |
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 33410350 | ||
| Pubmed | 7.70e-06 | 2 | 97 | 2 | 34146905 | ||
| Pubmed | 1.39e-05 | 52 | 97 | 4 | 9455477 | ||
| Pubmed | 1.48e-05 | 653 | 97 | 10 | 22586326 | ||
| Pubmed | 1.91e-05 | 407 | 97 | 8 | 12693553 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 28814779 | ||
| Pubmed | Dominant TOM1 mutation associated with combined immunodeficiency and autoimmune disease. | 2.31e-05 | 3 | 97 | 2 | 31263572 | |
| Pubmed | Critical role for scaffolding adapter Gab2 in Fc gamma R-mediated phagocytosis. | 2.31e-05 | 3 | 97 | 2 | 12821647 | |
| Pubmed | Unique properties of PTEN-L contribute to neuroprotection in response to ischemic-like stress. | 2.31e-05 | 3 | 97 | 2 | 30816308 | |
| Pubmed | [Expression and clinical significance of COX-2, p-Stat3, and p-Stat5 in esophageal carcinoma]. | 2.31e-05 | 3 | 97 | 2 | 17672932 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19233262 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 22194600 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18276758 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23023224 | ||
| Pubmed | Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia. | 2.31e-05 | 3 | 97 | 2 | 20201032 | |
| Pubmed | CD82 regulates STAT5/IL-10 and supports survival of acute myelogenous leukemia cells. | 2.31e-05 | 3 | 97 | 2 | 23797738 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 24289584 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 19796718 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 20651068 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 21930791 | ||
| Pubmed | Comparative FISH mapping of Gab1 and Gab2 genes in human, mouse and rat. | 2.31e-05 | 3 | 97 | 2 | 11701952 | |
| Pubmed | IL-2 and IL-7 induce heterodimerization of STAT5 isoforms in human peripheral blood T lymphoblasts. | 2.31e-05 | 3 | 97 | 2 | 9398404 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 18342552 | ||
| Pubmed | The Gab2-MALT1 axis regulates thromboinflammation and deep vein thrombosis. | 2.31e-05 | 3 | 97 | 2 | 35895897 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 23250732 | ||
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 16314834 | ||
| Pubmed | Gab2 and Gab3 Redundantly Suppress Colitis by Modulating Macrophage and CD8+ T-Cell Activation. | 2.31e-05 | 3 | 97 | 2 | 30936879 | |
| Pubmed | 2.31e-05 | 3 | 97 | 2 | 22126101 | ||
| Pubmed | Pramel7 mediates LIF/STAT3-dependent self-renewal in embryonic stem cells. | 2.32e-05 | 20 | 97 | 3 | 21425410 | |
| Pubmed | 3.12e-05 | 22 | 97 | 3 | 31729367 | ||
| Pubmed | 4.42e-05 | 335 | 97 | 7 | 15741177 | ||
| Pubmed | IL-23 and IL-2 activation of STAT5 is required for optimal IL-22 production in ILC3s during colitis. | 4.60e-05 | 4 | 97 | 2 | 32332067 | |
| Pubmed | Grb2-associated binder-1 is required for neuregulin-1-induced peripheral nerve myelination. | 4.60e-05 | 4 | 97 | 2 | 24872569 | |
| Pubmed | Differential effects of STAT proteins on growth hormone-mediated IGF-I gene expression. | 4.60e-05 | 4 | 97 | 2 | 25205818 | |
| Pubmed | Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility. | 4.60e-05 | 4 | 97 | 2 | 23401857 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 7719938 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 25352693 | ||
| Pubmed | [Expression and its significance of STAT3, STAT5, Survivin and Ki67 in nasal NK/T cell lymphoma]. | 4.60e-05 | 4 | 97 | 2 | 17225522 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 22806893 | ||
| Pubmed | The limited contribution of Fyn and Gab2 to the high affinity IgE receptor signaling in mast cells. | 4.60e-05 | 4 | 97 | 2 | 20335178 | |
| Pubmed | Cutting edge: role of STAT1, STAT3, and STAT5 in IFN-alpha beta responses in T lymphocytes. | 4.60e-05 | 4 | 97 | 2 | 15634877 | |
| Pubmed | The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo. | 4.60e-05 | 4 | 97 | 2 | 19171907 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 28722233 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 23696567 | ||
| Pubmed | Gab2, via PI-3K, regulates ARF1 in FcεRI-mediated granule translocation and mast cell degranulation. | 4.60e-05 | 4 | 97 | 2 | 21653832 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 32555380 | ||
| Pubmed | Gab2 deficiency prevents Flt3-ITD driven acute myeloid leukemia in vivo. | 4.60e-05 | 4 | 97 | 2 | 34903841 | |
| Pubmed | Tollip coordinates Parkin-dependent trafficking of mitochondrial-derived vesicles. | 4.60e-05 | 4 | 97 | 2 | 32311122 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 17639043 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 27840422 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 15485908 | ||
| Pubmed | STAT5 outcompetes STAT3 to regulate the expression of the oncogenic transcriptional modulator BCL6. | 4.60e-05 | 4 | 97 | 2 | 23716595 | |
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 12058075 | ||
| Pubmed | 4.60e-05 | 4 | 97 | 2 | 28422733 | ||
| Interaction | GOLGA4 interactions | 9.92e-06 | 226 | 93 | 8 | int:GOLGA4 | |
| Interaction | DNAJC6 interactions | 1.15e-05 | 64 | 93 | 5 | int:DNAJC6 | |
| Interaction | PCNT interactions | 1.58e-05 | 241 | 93 | 8 | int:PCNT | |
| Interaction | GYPA interactions | 1.61e-05 | 174 | 93 | 7 | int:GYPA | |
| Interaction | FAM186B interactions | 2.03e-05 | 12 | 93 | 3 | int:FAM186B | |
| Interaction | EDNRB interactions | 3.09e-05 | 39 | 93 | 4 | int:EDNRB | |
| Interaction | LUC7L2 interactions | 3.70e-05 | 353 | 93 | 9 | int:LUC7L2 | |
| Interaction | NRCAM interactions | 3.78e-05 | 41 | 93 | 4 | int:NRCAM | |
| Cytoband | 8p22 | 8.53e-05 | 40 | 97 | 3 | 8p22 | |
| Cytoband | 14q23.1 | 1.39e-04 | 47 | 97 | 3 | 14q23.1 | |
| Cytoband | 1p36.21 | 3.31e-04 | 63 | 97 | 3 | 1p36.21 | |
| GeneFamily | PRAME family | 7.75e-05 | 24 | 63 | 3 | 686 | |
| GeneFamily | WD repeat domain containing | 2.98e-04 | 262 | 63 | 6 | 362 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 4.23e-04 | 9 | 63 | 2 | 1230 | |
| GeneFamily | PHD finger proteins|NuRD complex | 7.71e-04 | 12 | 63 | 2 | 1305 | |
| GeneFamily | Fibronectin type III domain containing | 2.35e-03 | 160 | 63 | 4 | 555 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 3.88e-06 | 191 | 97 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-06 | 194 | 97 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.63e-06 | 197 | 97 | 6 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.63e-06 | 197 | 97 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.05e-06 | 200 | 97 | 6 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-05 | 154 | 97 | 5 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-05 | 154 | 97 | 5 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | 10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 2.81e-05 | 162 | 97 | 5 | b4535bcb3f469bc139e73f1122f4070013e5a1de | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_2|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.06e-05 | 165 | 97 | 5 | 731147b4337fd0de4383dc8170b4f9ccd98caec6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.44e-05 | 169 | 97 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Control-Lymphoid-Tregs|Lymphoid / Condition, Lineage and Cell class | 3.95e-05 | 174 | 97 | 5 | 522a6d5d9809271c63b85f62ac6ec52a6e3c355e | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.06e-05 | 175 | 97 | 5 | f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.17e-05 | 176 | 97 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.28e-05 | 177 | 97 | 5 | da8802a6351d3e510822f82e2fde8a4314a2216e | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.28e-05 | 177 | 97 | 5 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.15e-05 | 184 | 97 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.28e-05 | 185 | 97 | 5 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 5.42e-05 | 186 | 97 | 5 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.99e-05 | 190 | 97 | 5 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 190 | 97 | 5 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.99e-05 | 190 | 97 | 5 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-AC-like-AC-like_Prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.30e-05 | 192 | 97 | 5 | d6f656be2698bd215717d35f4e7ab727c08c61e0 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.46e-05 | 193 | 97 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | COVID-19-kidney-Glomerular_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.61e-05 | 194 | 97 | 5 | 660535b492445063d965095a50e1e299ce04c50a | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.61e-05 | 194 | 97 | 5 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 6.78e-05 | 195 | 97 | 5 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 6.78e-05 | 195 | 97 | 5 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.11e-05 | 197 | 97 | 5 | 27c044833e471a312a572e0b1c83e4bc8a36e896 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.11e-05 | 197 | 97 | 5 | f7eaac1c321710a55e09ffb047a7db2baf7b7e28 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_dorsal_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 7.28e-05 | 198 | 97 | 5 | 5f0964c3aa7e1dc52cbb46e754078920b65bcb88 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.28e-05 | 198 | 97 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 7.28e-05 | 198 | 97 | 5 | 629d674a9c9108c1acb3f7af57bbdbf34bb0528e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.46e-05 | 199 | 97 | 5 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Proliferating-cycling_dorsal_progenitors|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 7.46e-05 | 199 | 97 | 5 | ca17e8c0f5bc2c41ce28351a7418d934404e563b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.46e-05 | 199 | 97 | 5 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.64e-05 | 200 | 97 | 5 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / Treatment groups by lineage, cell group, cell type | 7.64e-05 | 200 | 97 | 5 | eb94a5111ef0e903ee5be9f7efe571b4e6d5fce1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.64e-05 | 200 | 97 | 5 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | (09)_Interm._secr.>cil.|World / shred by cell type by condition | 7.64e-05 | 200 | 97 | 5 | 3305e14dba12e94da42f0414fdc7a2c8caf0a183 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.64e-05 | 200 | 97 | 5 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| Computational | Neighborhood of FOSL1 | 1.45e-04 | 406 | 53 | 9 | MORF_FOSL1 | |
| Computational | Neighborhood of MSH3 | 1.76e-04 | 243 | 53 | 7 | MORF_MSH3 | |
| Computational | Neighborhood of BRCA1 | 2.85e-04 | 263 | 53 | 7 | MORF_BRCA1 | |
| Computational | Neighborhood of ATRX | 6.26e-04 | 215 | 53 | 6 | MORF_ATRX | |
| Computational | Neighborhood of HEAB | 7.26e-04 | 83 | 53 | 4 | MORF_HEAB | |
| Computational | Neighborhood of PPP5C | 1.03e-03 | 91 | 53 | 4 | MORF_PPP5C | |
| Computational | Neighborhood of ATF2 | 1.10e-03 | 330 | 53 | 7 | MORF_ATF2 | |
| Disease | T-Cell Large Granular Lymphocyte Leukemia | 9.83e-06 | 2 | 93 | 2 | C1955861 | |
| Disease | angiosarcoma (is_implicated_in) | 5.87e-05 | 4 | 93 | 2 | DOID:0001816 (is_implicated_in) | |
| Disease | colon adenocarcinoma (is_implicated_in) | 7.48e-05 | 26 | 93 | 3 | DOID:234 (is_implicated_in) | |
| Disease | insomnia measurement | 8.10e-05 | 443 | 93 | 8 | EFO_0007876 | |
| Disease | systemic scleroderma, Crohn's disease | 9.77e-05 | 5 | 93 | 2 | EFO_0000384, EFO_0000717 | |
| Disease | platelet component distribution width | IQGAP2 BMP2K SYNE1 TLCD4 MTSS1 GAB2 BAZ2A MACF1 SEC14L5 BRWD1 | 1.35e-04 | 755 | 93 | 10 | EFO_0007984 |
| Disease | DIABETES MELLITUS, PERMANENT NEONATAL | 2.04e-04 | 7 | 93 | 2 | C1833104 | |
| Disease | peripheral arterial disease, traffic air pollution measurement | 3.80e-04 | 194 | 93 | 5 | EFO_0004265, EFO_0007908 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 7.98e-04 | 131 | 93 | 4 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 7.98e-04 | 131 | 93 | 4 | C4552091 | |
| Disease | Juvenile arthritis | 7.98e-04 | 131 | 93 | 4 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 7.98e-04 | 131 | 93 | 4 | C3714758 | |
| Disease | calcium measurement | 8.39e-04 | 628 | 93 | 8 | EFO_0004838 | |
| Disease | multiple myeloma, monoclonal gammopathy | 8.72e-04 | 14 | 93 | 2 | EFO_0000203, EFO_0001378 | |
| Disease | Juvenile-Onset Still Disease | 8.93e-04 | 135 | 93 | 4 | C0087031 | |
| Disease | T-Cell Lymphoma | 1.15e-03 | 16 | 93 | 2 | C0079772 | |
| Disease | hemoglobin A1 measurement | 1.30e-03 | 520 | 93 | 7 | EFO_0007629 | |
| Disease | cognitive function measurement | NMNAT2 TMEM161B VPS8 MTSS1 ZBTB9 NBEA NME9 RYR3 PRR12 ASAP2 VWA3B EPHA5 | 1.81e-03 | 1434 | 93 | 12 | EFO_0008354 |
| Disease | bone density, lean body mass | 1.98e-03 | 21 | 93 | 2 | EFO_0003923, EFO_0004995 | |
| Disease | fatty acid measurement | 2.60e-03 | 436 | 93 | 6 | EFO_0005110 | |
| Disease | Neonatal diabetes mellitus | 2.81e-03 | 25 | 93 | 2 | C0158981 | |
| Disease | Intellectual Disability | 2.94e-03 | 447 | 93 | 6 | C3714756 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ENIASAMVIWINEIL | 451 | O60347 | |
| TIMPTLEEWEALCQQ | 431 | Q8N163 | |
| ESVNLTCKQWLQMEE | 401 | Q68DN1 | |
| QNLNMTVAQDWCLAL | 681 | Q9HCE6 | |
| QWCEQVEIADENNML | 51 | Q7Z7A1 | |
| NVEEIVINNTRFLMW | 51 | Q9Y689 | |
| AVLQWVEELEQRVIM | 1516 | Q9UIF9 | |
| WVVLNQGREIVQTMN | 551 | P49747 | |
| VCKVMEQNQNNWLLT | 101 | P54756 | |
| LNIADLVIFTWMEVQ | 1526 | Q96DT5 | |
| VNSISDNVWEVLILM | 116 | Q9NSY1 | |
| MQVEVQSLSLEECPW | 1 | Q8WU49 | |
| CMEKVQAWLQENLGI | 216 | P27701 | |
| ILQQEQWMNVCVGDI | 141 | P98198 | |
| QWMNVCVGDIIKLEN | 146 | P98198 | |
| QIQQEQLDSVMDWLT | 446 | Q969V3 | |
| WEMLCGNEVQILSNL | 226 | Q96TA1 | |
| LVILDMCGNIIIWNQ | 1026 | Q6ZRR7 | |
| WEQNVHNIVMVTQCV | 1791 | P23467 | |
| MNWVNDSIIQEFILL | 1 | P58173 | |
| QEWMIKSINNNTAIC | 386 | Q6P0N0 | |
| VMQACVAEDQLVVKW | 331 | Q8NI17 | |
| SPVIDQFIECVWQLM | 396 | Q9Y216 | |
| DEQECQIWMSVLQNS | 381 | O43150 | |
| MVWQNTENALLETVI | 486 | Q63HM2 | |
| IDCLINPLQEQMEEW | 101 | O43312 | |
| IMQALCWVHDDLNQV | 451 | O00443 | |
| EELDWCLEQLETMQT | 236 | P27815 | |
| NQVVEWFVQIAMALQ | 106 | P51957 | |
| QQLNKCIEILNDMVW | 841 | Q9ULK4 | |
| VELVMLLCSQEWQNS | 1851 | P50851 | |
| AVLDLASLQWVAMQC | 786 | Q9UBG0 | |
| ASLQWVAMQCDTQLD | 791 | Q9UBG0 | |
| QEALEVIQLNIQWME | 1001 | Q9UIQ6 | |
| SAAVQSQLQWMKQLC | 761 | Q9UPN3 | |
| PWVICSVSEDNIMQI | 386 | Q16576 | |
| ALCLMLVQVIIAVEW | 166 | Q9NZH0 | |
| VLLMDIWNSEDQVQI | 136 | O95302 | |
| LQQMIQAVVDNVCWQ | 86 | Q9UHY7 | |
| FQLQMLQIVCSDTWA | 1026 | Q9P218 | |
| TREDMNEWVQSICQI | 136 | Q2WGN9 | |
| AIEACVMWLLENEFI | 581 | O75417 | |
| IMQVKCLTAELSQWQ | 61 | Q9BS16 | |
| NLELQMEDCEEWRVQ | 331 | Q5T5S1 | |
| MIAWNQNDSIVVTAV | 431 | Q9NSI6 | |
| LCEEENLLQVVWHSM | 836 | Q9NV70 | |
| LSVMLEVALNQVDVW | 56 | Q9Y3B6 | |
| LLEQDQQVWMEECAL | 586 | P57679 | |
| QQVWMEECALSSVLQ | 591 | P57679 | |
| TGTILQNNMKELWCV | 311 | Q5T890 | |
| SWVSELQLELHCQVM | 556 | Q14839 | |
| MQESCLIQLRHWLQE | 241 | O43304 | |
| LVCVNAWMLDLTQAI | 146 | O75751 | |
| LQVLDLQDVCENFWM | 6 | H0Y7S4 | |
| TEEDMNKWVQSICQI | 101 | Q9UQC2 | |
| FDINSLWNNLCQIIM | 286 | P59534 | |
| VADQMTLLQNCWSEL | 291 | Q13285 | |
| DMLAVACVNQWEQLR | 371 | Q96LD4 | |
| CMWVQDEPLLQEELA | 61 | Q14684 | |
| MLWLEQPENIATCIA | 106 | Q6GMV3 | |
| EMVETQINSVKCWVQ | 5326 | Q8NF91 | |
| TQEMNISLVWCLLVL | 131 | Q8NDZ6 | |
| MVWNTDLVETLELQN | 556 | P31040 | |
| VCNQIDQIMPTWIKD | 616 | Q5H9M0 | |
| LSWNEIQNCIDMVNA | 431 | Q13576 | |
| KQWVTLVVDVNQCLE | 536 | Q13576 | |
| VVELVMLLCSQEWQN | 1936 | Q8NFP9 | |
| LQAEMDCELQSSLQW | 401 | A0A0B4J2F2 | |
| LQAEMDCELQSSLQW | 401 | P57059 | |
| YKIQELQCQILSWMQ | 721 | Q5VXU9 | |
| MAVWIQAQQLQGEAL | 1 | P51692 | |
| WIRNATVNILEEMNL | 66 | Q8WX94 | |
| AVWVSEVMLQQTQVA | 126 | Q9UIF7 | |
| ITSLDIQQVVLMCWE | 661 | Q8N3P4 | |
| IQQVVLMCWENRLYD | 666 | Q8N3P4 | |
| DLNWCVISDMEVIEL | 41 | Q9H169 | |
| QEEVVQQCMRNQPWL | 2001 | Q9ULL5 | |
| SMVSWQDILQQINEI | 66 | Q6Q759 | |
| QICNLVAIDTNQLMW | 416 | Q09428 | |
| VLNVQTVEEVVMWCL | 136 | Q9UKV5 | |
| AWVVEIQMLKCRVDN | 116 | Q8N1N0 | |
| LWQKIHESIVMDLCQ | 1581 | Q6P2Q9 | |
| QVLDLQDVCENFWMV | 101 | Q5VXH4 | |
| VWALASMELVIQFQV | 1461 | Q96KV7 | |
| EASQTIWVNCQVSME | 356 | P0CB48 | |
| SQTMICWAQEDQIQD | 1961 | Q15413 | |
| QSEDWALNMEICDII | 26 | O60784 | |
| VTQACLMEDIEQWLS | 411 | O60784 | |
| VVVISNICQMPNAWA | 461 | P40763 | |
| QVLDLQDVCENFWMV | 101 | Q5TYX0 | |
| QLSWVISCVVLDVMN | 216 | Q96MV1 | |
| QVNISTQELWEEMLS | 11 | Q86XW9 | |
| LSCLMFVWINIEQET | 736 | O95427 | |
| QMWQVVDQCSEILRE | 126 | Q96C00 | |
| WQEMEEACSTLAQIQ | 341 | Q502W6 | |
| VIMWNLDECREKVLQ | 96 | A2RRH5 | |
| QSEDWTLNMEICDII | 26 | Q6ZVM7 | |
| QENSEIMNSLIESWC | 1561 | Q8IWV8 | |
| CQLIERILEAWEMNE | 431 | Q5H9R7 | |
| LVDWTMQALNLQVAL | 431 | Q69YN4 | |
| SISLWICVQIVIEMQ | 31 | Q6NUM6 | |
| ENSLIQWVEQEIMSR | 921 | Q9BVV6 | |
| WLRMFDQQEIQVLIS | 951 | Q15386 | |
| TICSMNSNIWQICIQ | 616 | O43156 | |
| RLIMCQLAVQNSDWI | 66 | Q9BZQ4 |